Egalet (EGLT) Granted Tentative FDA Approval for Expanded Label for ARYMO ER (morphine sulfate) C-II
Tweet Send to a Friend
Egalet Corporation (NAASDAQ: EGLT) today announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval for an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
